Star Imaging And Path Lab Ltd

Star Imaging And Path Lab Ltd has filed its Monitoring Agency Report for the quarter ended June 30, 2026, as required by SEBI regulations. The report, issued by Infomerics Valuation and Rating Limited, confirms nil deviation from the objects for which the IPO proceeds of Rs. 55.66 crore were earmarked. The monitoring agency has declared that the report provides an objective view of the utilization of issue proceeds based on information provided by the issuer and other reliable sources. The report also includes declarations regarding the absence of conflicts of interest and a confirmation that it presents a true and fair view.

Star Imaging and Path Lab Ltd has upgraded its diagnostic centre in Tilak Nagar, New Delhi, by installing a Toshiba Aquilion ONE 1184 Slice/Second CT Scanner. This advanced imaging technology significantly enhances diagnostic capabilities, offering superior speed, accuracy, image quality, and patient comfort. The upgrade underscores the company's commitment to improving healthcare infrastructure and diagnostic outcomes, reinforcing its position as a leading healthcare services provider in North India.

Star Imaging And Path Lab Ltd approved the audited standalone and consolidated financial statements for the half and year ended March 31, 2026, during a board meeting held on May 22, 2026. The auditors, BHS & Co, issued an unmodified opinion on the audited financial results. The financial results are available on the company's website.

Star Imaging And Path Lab Ltd approved the audited standalone and consolidated financial results for the half and financial year ended March 31, 2026, during its Board of Directors meeting held on May 22, 2026. The auditors, BHS & Co, issued an audit report with an unmodified opinion on the financial results. The results are available on the company's website.

Star Imaging And Path Lab Ltd has scheduled a Board of Directors meeting on May 22, 2026, to consider and approve the audited standalone and consolidated financial results for the half and financial year ended March 31, 2026. The trading window, which was closed on April 1, 2026, will re-open 48 hours after the declaration of the financial results. The information is available on the company's website.

Star Imaging And Path Lab Ltd has appointed NeoAtlas Capital Advisory LLP as its Investor Relations and Strategic Communications Advisor, effective May 14, 2026. This move aims to strengthen the company's investor engagement, enhance transparency, and improve capital markets communication. NeoAtlas Capital will support Star Imaging in its investor outreach and communication initiatives. The registered office of NeoAtlas Capital is located in Ahmedabad, Gujarat.

Star Imaging And Path Lab Ltd has released a Monitoring Agency Report for the quarter ended March 31, 2026, as per Regulation 32(6) of the SEBI (Listing Obligations & Disclosures Requirements) Regulations, 2015. The report, issued by Infomerics Valuation and Rating Limited, pertains to the utilization of IPO proceeds. The report indicates no deviation from the stated objectives of the IPO.

Star Imaging And Path Lab Ltd confirms that it is not identified as a “Large Corporate” as of March 31, 2026. Consequently, the company is not required to file the Annual Disclosure in Annexure B2 for the financial year 2026-27, as per SEBI circulars regarding fund raising by issuance of debt securities by large entities.

Star Imaging And Path Lab Ltd responded to a query regarding significant share price movement, stating that all material information and events have been timely and accurately disclosed as per SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company confirmed that, to its knowledge, there is no undisclosed material information or event that could impact the price or volume of its securities. It attributed the price movement to purely market-driven factors, general market conditions, and speculative activities, over which management has no control. Furthermore, the company stated that its Promoters, Promoter Group, and Key Managerial Personnel have not traded in the company's securities recently, reiterating its commitment to regulatory compliance.

Star Imaging And Path Lab Ltd has announced the opening of a new diagnostic and imaging centre at Dwarka, New Delhi. The new centre, which is part of the company's expansion strategy, is set to commence operations from 1st August 2026, subject to regulatory approvals. The lease agreement for the new centre, worth approximately ₹ 14 Crore, is expected to contribute positively to the company's revenue and operations.